1
Clinical Trials associated with Human Fibrinogen(Green Cross China)评价人纤维蛋白原在先天性纤维蛋白原减少或缺乏症患者中的有效性和安全性的上市后临床研究
[Translation] Post-marketing clinical study to evaluate the efficacy and safety of human fibrinogen in patients with congenital fibrinogen deficiency or deficiency
1)通过单次给药的简易PK研究,探索本品的部分关键药代动力学(PK)特征,为本品用量计算提供依据;
2)评价本品在上市后治疗先天性纤维蛋白原减少或缺乏症患者的有效性和安全性。
[Translation] 1) Through a simple PK study of a single dose, explore some key pharmacokinetic (PK) characteristics of this product to provide a basis for the dosage calculation of this product;
2) Evaluate the efficacy and safety of this product in the treatment of patients with congenital fibrinogen deficiency or deficiency after marketing.
100 Clinical Results associated with Human Fibrinogen(Green Cross China)
100 Translational Medicine associated with Human Fibrinogen(Green Cross China)
100 Patents (Medical) associated with Human Fibrinogen(Green Cross China)
100 Deals associated with Human Fibrinogen(Green Cross China)